MARKET OPEN: Covid drug trial sets upbeat tone for local trading

MARKET OPEN: Covid drug trial sets upbeat tone for local trading
Paul McBeth
New Zealand’s stock market may be in for a positive start to the week after Wall Street closed stronger on Friday on optimism over a late-stage trial of the Remdesivir drug in treating covid-19. Investor optimism over the economic recovery from the covid-19 pandemic was stoked by drug company Gilead’s news that its antiviral remdesivir product significantly aided the recovery of severely ill patients. Australia’s Therapeutics Goods Administration gave provisional approval for remdesivir to be used in adults with severe covid symptoms. “Gi...

More Markets

NZ sharemarket enjoys good week with fourth gain
Markets Market close

NZ sharemarket enjoys good week with fourth gain

The S&P/NZX 50 Index closed at 11,938.08, up 64.04 points or 0.54%.

Graham Skellern 03 May 2024
BHP CEO flies to South Africa to push $65.4 billion takeover
Markets

BHP CEO flies to South Africa to push $65.4 billion takeover

The executives have already begun conversations with key stakeholders.

Bloomberg 03 May 2024
Rakon shareholder wants light shed on $400m bid
Markets

Rakon shareholder wants light shed on $400m bid

US giant Skyworks could be Rakon's new owner. One shareholder wants it to confirm.